Halozyme Dips on Royalty Statement
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today confirmed that the Company expects zero to minimal royalty revenue impact based on its analysis of the final rule for the Medicare Drug Price Negotiation ...
Stocks in Play: Satellos Bioscience Inc.
Announced that, following feedback from the U.S. Food and Drug Administration (FDA), it has selected change in vastus lateralis fat fraction measured by magnetic resonance imaging (MRI) as the primary ...
Last Updated:
Analyst Ratings
Analysts at Stifel initiated coverage on Atha Energy Corp. with a "BUY" rating and a target of $2.25
Crypto News
Research Reports
Rockstone Research
Homerun Resources Inc.
Rockstone Research
Lux Metals Corp
Edison Investment Research
Canadian General Investments
Most Popular
Latest News
Stocks in Play: McCoy Global Inc. 15 mHalozyme Dips on Royalty Statement 17 m
Stocks in Play: Satellos Bioscience Inc. 28 m
Cineplex, First Canadian Graphite, NFI at 52-Week Highs on News 31 m
USD / CAD - Canadian Dollar sinks on global risk aversion 34 m
Crypto Dragged Lower In Market Rout 35 m
Goldman Sachs Lowers Its Price Target On Gold 37 m
Tesla Ends Production Of The Cybertruck 40 m
ETFs
Forex Daily Briefing
More from BayStreet
Full calendar- IVEY Purchasing Managers Index: 10:00am11/6/2026
- Labour Force Survey: 8:30am 11/6/2026
- TSX New Listing: Fireweed Metals Corp. 11/5/2026
- Canadian International Merchandise Trade: 8:30am 11/4/2026
- TSX New Listing: Maritime Launch Services Inc. 11/3/2026
- TSX New Listing: Purpose Active Equity Fund 11/3/2026